onr:"swepub:oai:gup.ub.gu.se/257853"
Search: onr:"swepub:oai:gup.ub.gu.se/257853" > Sympathetic Respons...
- 1 of 1
- Previous record
- Next record
- To hitlist
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study
- Hopper, I. (author)
- Gronda, E. (author)
- Hoppe, U. C. (author)
- show more...
- Marwick, T. H. (author)
- Shetty, S. (author)
- Hayward, C. (author)
- Lambert, T. (author)
- Hering, D. (author)
- Esler, M. (author)
- Schlaich, M. (author)
- Walton, A. (author)
- Airoldi, F. (author)
- Brandt, M. C. (author)
- Cohen, S. A. (author)
- Reiters, P. (author)
- Krum, H. (author)
- show less...
- (creator_code:org_t)
- Elsevier BV, 2017
- 2017
- English.
- In: Journal of Cardiac Failure. - : Elsevier BV. - 1071-9164. ; 23:9, s. 702-707
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Background: Heart failure (HF) is associated with chronic sympathetic activation. Renal denervation (RDN) aims to reduce sympathetic activity by ablating the renal sympathetic nerves. We investigated the effect of RDN in patients with chronic HF and concurrent renal dysfunction in a prospective, multicenter, single-arm feasibility study. Methods and Results: Thirty-nine patients with chronic systolic HF (left ventricular ejection fraction [LVEF] <40%, New York Heart Association class II-III,) and renal impairment (estimated glomerular filtration rate [eGFR; assessed with the use of the Modification of Diet in Renal Disease equation] < 75 mL . min(-1) . 1.73 m(-2)) on stable medical therapy were enrolled. Mean age was 65 +/- 11 years; 62% had ischemic HF. The average number of ablations per patient was 13 +/- 3. No protocol-defined safety events were associated with the procedure. One subject experienced a renal artery occlusion that was possibly related to the denervation procedure. Statistically significant reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP; 1530 +/- 1228 vs 1428 +/- 1844 ng/mL; P = .006) and 120-minute glucose tolerance test (11.2 +/- 5.1 vs 9.9 +/- 3.6; P = .026) were seen at 12 months, but there was no significant change in LVEF (28 +/- 9% vs 29 +/- 11%; P = .536), 6-minute walk test (384 +/- 96 vs 391 +/- 97 m; P = .584), or eGFR (52.6 +/- 15.3 vs 52.3 +/- 18.5 mL . min(-1) . 1.73 m(-2); P = .700). Conclusions: RDN was associated with reductions in NT-proBNP and 120-minute glucose tolerance test in HF patients 12 months after RDN treatment. There was no deterioration in other indices of cardiac and renal function in this small feasibility study.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- Sympathetic nervous system
- chronic kidney disease
- renal impairment
- left-ventricular hypertrophy
- randomized controlled-trial
- resistant
- hypertension
- systolic function
- catheter
- safety
- pilot
- Cardiovascular System & Cardiology
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Journal of Cardiac Failure (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hopper, I.
- Gronda, E.
- Hoppe, U. C.
- Rundqvist, Bengt ...
- Marwick, T. H.
- Shetty, S.
- show more...
- Hayward, C.
- Lambert, T.
- Hering, D.
- Esler, M.
- Schlaich, M.
- Walton, A.
- Airoldi, F.
- Brandt, M. C.
- Cohen, S. A.
- Reiters, P.
- Krum, H.
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cardiac and Card ...
- Articles in the publication
- Journal of Cardi ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
